BELOTTI DANIELA

Lussana, F., Magnani, C., Galimberti, S., Gritti, G., Gaipa, G., Belotti, D., et al. (2025). Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation. BLOOD CANCER JOURNAL, 15(1) [10.1038/s41408-025-01260-6]. Dettaglio

Genchi, A., Brambilla, E., Sangalli, F., Radaelli, M., Bacigaluppi, M., Furlan, R., et al. (2023). Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study. NATURE MEDICINE, 29, 75-85 [10.1038/s41591-022-02097-3]. Dettaglio

Zanier, E., Pischiutta, F., Rulli, E., Vargiolu, A., Elli, F., Gritti, P., et al. (2023). MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial. INTENSIVE CARE MEDICINE EXPERIMENTAL, 11(1) [10.1186/s40635-023-00535-1]. Dettaglio

Capelli, C., Frigerio, S., Lisini, D., Nava, S., Gaipa, G., Belotti, D., et al. (2022). A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies. CYTOTHERAPY, 24(5), 544-556 [10.1016/j.jcyt.2021.12.004]. Dettaglio

Rambaldi, B., Galimberti, S., Rizzuto, G., Magnani, C., Buracchi, C., Risca, G., et al. (2022). Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response. In 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) (pp.10339-10340). ELSEVIER [10.1182/blood-2022-166788]. Dettaglio